Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 850 Records) |
Query Trace: UGT1A1[original query] |
---|
Phase II study of IRInotecan treatment after COmbined chemo-immunotherapy for extensive-stage small cell lung cancer: Protocol of IRICO study. Thoracic cancer 2023 9 . Hiromi Tomono, Hirokazu Taniguchi, Minoru Fukuda, Takaya Ikeda, Seiji Nagashima, Kazumasa Akagi, Sawana Ono, Yasuhiro Umeyama, Midori Shimada, Hiroshi Gyotoku, Shinnosuke Takemoto, Yasushi Hisamatsu, Ryotaro Morinaga, Ryuta Tagawa, Ryosuke Ogata, Yosuke Dotsu, Hiroaki Senju, Hiroshi Soda, Katsumi Nakatomi, Fumiko Hayashi, Nanae Sugasaki, Akitoshi Kinoshita, Hiroshi Muk |
Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1. Clinical pharmacokinetics 2023 9 . Mirjam de With, Leni van Doorn, Esmay Kloet, Anne van Veggel, Maja Matic, Micha J de Neijs, Esther Oomen-de Hoop, Esther van Meerten, Ron H N van Schaik, Ron H J Mathijssen, Sander Bi |
[Combined effect of PNPLA3 rs738409 and UGT1A1 rs10929303 gene polymorphisms on nonalcoholic fatty liver disease in children]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 2023 8 31 (7): 723-728. P P Zhang, J Y Song, H J Wang, H Wa |
Pilot Study: Personalized Medicine in Endoscopy, Can Pharmacogenomics Predict Response to Conscious Sedation? Journal of personalized medicine 2023 7 13 (7): . Himesh B Zaver, Hassan Ghoz, Balkishan Malviya, Aman Bali, Samuel Antwi, Ann M Moyer, Yan |
The Genetics of Glucose-6-Phosphate-Dehydrogenase (G6PD) and Uridine Diphosphate Glucuronosyl Transferase 1A1 (UGT1A1) Promoter Gene Polymorphism in Relation to Quantitative Biochemical G6PD Activity Measurement and Neonatal Hyperbilirubinemia. Children (Basel, Switzerland) 2023 7 10 (7): . Arieh Riskin, Yulia Bravdo, Clair Habib, Irit Maor, Julnar Mousa, Sizett Shahbarat, Elena Shahak, Adel Shala |
Association of Low Serum Bilirubin Concentrations and Promoter Variations in the UGT1A1 and HMOX1 Genes with Type 2 Diabetes Mellitus in the Czech Population. International journal of molecular sciences 2023 7 24 (13): . Alena Jirásková, Jan Škrha, Libor Vít |
Association Between Serum Bilirubin and Atrial Fibrillation: A Mendelian Randomization Study. Korean circulation journal 2023 6 . Si-Woo Kim, Jung-Ho Yang, Sun-Seog Kweon, Young-Hoon Lee, Seong-Woo Choi, So-Yeon Ryu, Hae-Sung Nam, Hye-Yeon Kim, Min-Ho Sh |
[Factors influencing bilirubin elevation and its correlation with UGT1A1 gene polymorphism in the early postoperative period of transjugular intrahepatic portosystemic shunt]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 2023 6 31 (5): 524-531. B F Zhang, J Fang, Z Q Zhang, X L Ao, L Xia, H C Wu, S A Zhang, Z X Wu, D L |
Predictive Value of ABCC2 and UGT1A1 Polymorphisms on Irinotecan-Related Toxicities in Patients with Cancer. Genetic testing and molecular biomarkers 2023 5 27 (5): 133-141. Zineb Aoullay, Andrew Smith, Meriem Slaoui, Ihssane El Bouchikhi, Hassan Ghazal, Najib Al Idrissi, Bouchra Meddah, Kara L Lynch, Yahia Cherrah, Alan H B |
[A family study of the compound heterozygous mutation of the UGT1A1 gene causing Crigler-Najjar syndrome type II]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 2023 5 31 (2): 168-173. L Luo, X B Yao, S J Zheng, W L Ya |
A single-center retrospective analysis of the efficacy and safety of a modified regimen of irinotecan plus S-1 (IRIS) with molecular targeting agents as second-line chemotherapy in Japanese patients with recurrent or nonresectable colorectal cancer. Journal of gastrointestinal oncology 2023 5 14 (2): 663-675. Shigeo Higami, Masaya Mukai, Daiki Yokoyama, Syuji Uda, Rin Abe, Nana Mamuro, Kyoko Kishima, Sayuri Hasegawa, Takayuki Tajima, Eiji Nomura, Hiroyasu Makuuc |
Pharmacogenomic profile of a central European urban random population-Czech population. PloS one 2023 4 18 (4): e0284386. Riccardo Proietti, Geraldo A Maranho Neto, Sarka Kunzova, Oriana Lo Re, Ari Ahola-Olli, Juho Heliste, Juan Pablo Gonzalez-Rivas, Manlio Vinciguer |
Red Blood Cell Membrane-Related Gene Variants and Clinical Risk Factors in Chinese Neonates with Hyperbilirubinemia. Neonatology 2023 4 1-10. Lin Fen, Xu Jia-Xin, Wu Yong-Hao, Chen Zi-Kai, Chen Man-Tong, Ma Yu-Bin, Li Jian-Dong, Yang Li- |
Polymorphisms in gene UGT1A1 modify the association of prenatal exposure to polycyclic aromatic hydrocarbons with congenital heart diseases risk. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2023 3 36 (1): 2183743. Tao Jing, Li Nana, Liu Zhen, Deng Ying, Li Xiaohong, Luo Fangfang, Li Xiaoyan, Yu Ping, Zhu J |
Correlation of UGT1A1 Gene Polymorphisms or Prior Irinotecan Treatment and Treatment Outcomes of Nanoliposomal-Irinotecan plus 5-Fluorouracil/Leucovorin for Pancreatic Ductal Adenocarcinoma: A Multicenter, Retrospective Cohort Study (HGCSG2101). Journal of clinical medicine 2023 2 12 (4): . Harada Kazuaki, Yamamura Takahiro, Muto Osamu, Nakamura Michio, Sogabe Susumu, Sawada Kentaro, Nakano Shintaro, Yagisawa Masataka, Muranaka Tetsuhito, Dazai Masayoshi, Tateyama Miki, Kobayashi Yoshimitsu, Kato Sosuke, Hatanaka Kazuteru, Kawamoto Yasuyuki, Yuki Satoshi, Sakata Yuh, Sakamoto Naoya, Komatsu Yoshi |
Impact of polymorphisms in CYP and UGT enzymes and ABC and SLCO1B1 transporters on the pharmacokinetics and safety of desvenlafaxine. Frontiers in pharmacology 2023 2 14 1110460. Calleja Sofía, Zubiaur Pablo, Ochoa Dolores, Villapalos-García Gonzalo, Mejia-Abril Gina, Soria-Chacartegui Paula, Navares-Gómez Marcos, de Miguel Alejandro, Román Manuel, Martín-Vílchez Samuel, Abad-Santos Francis |
Pharmacogenetics in critical care: association between CYP3A5 rs776746 A/G genotype and acetaminophen response in sepsis and septic shock. BMC anesthesiology 2023 2 23 (1): 55. Scorcella C, Domizi R, Amoroso S, Carsetti A, Casarotta E, Castaldo P, D'angelo C, Damiani E, Gasparri F, Donati A, Adrario |
UGT1A1 genotype-guided irinotecan dosing during neoadjuvant chemoradiotherapy for locally advanced rectal cancer: A prospective analysis of SN-38 concentration. International journal of cancer 2023 12 . Pei-Cheng Jiang, Shuo-Wen Wang, Chao Li, Jin Fan, Ji Z |
Direct Comparative Analysis of a Pharmacogenomics Panel with PacBio Hifi Long-Read and Illumina Short-Read Sequencing. Journal of personalized medicine 2023 12 13 (12): . David Barthélémy, Elodie Belmonte, Laurie Di Pilla, Claire Bardel, Eve Duport, Veronique Gautier, Léa Pay |
Real-World Outcomes of First-Line FOLFIRI Plus Bevacizumab with Irinotecan Dose Escalation versus FOLFOXIRI Plus Bevacizumab in BRAF-Mutant Metastatic Colorectal Cancer: The Preliminary Data from a Single-Center Observational Study. Medicina (Kaunas, Lithuania) 2023 12 59 (12): . Hsiang-Lin Tsai, Ching-Wen Huang, Yen-Cheng Chen, Wei-Chih Su, Tsung-Kun Chang, Po-Jung Chen, Ching-Chun Li, Yu-Tang Chang, Jaw-Yuan Wa |
A phase-II study based on dose adjustment according to UGT1A1 polymorphism: is irinotecan underdosed in first-line FOLFIRI regimen for mCRC? Cancer chemotherapy and pharmacology 2023 11 . Angeline Ginzac, Emilie Thivat, Caroline Petorin, Damien Richard, Pauline Herviou, Ioana Molnar, Hervé Devaud, Isabelle Creveaux, Florent Ferrer, Nicolas Authier, Marine Jary, Denis Pezet, Xavier Duran |
Genetic Polymorphisms of UDP-Glucuronosyltransferases and Susceptibility to Antituberculosis Drug-Induced Liver Injury: A Systematic Review and Meta-Analysis. Journal of tropical medicine 2023 10 2023 5044451. Xinyu Chen, Zhuolu Hao, Nannan Wang, Jia Zhu, Honggang Yi, Shaowen Ta |
UGT1A polymorphism rs4148324 associated with topiramate plasma concentration to dose ratio in children with epilepsy. Seizure 2023 10 . Shifeng Wei, Xingmeng Li, Han Wu, Qiang Zhang, Yun Wu, Zhigang Zhao, Shenghui Mei, Weixing Fe |
Dolutegravir pharmacokinetics in Ugandan patients with TB and HIV receiving standard- versus high-dose rifampicin. Antimicrobial agents and chemotherapy 2023 10 e0043023. Allan Kengo, Ruth Nabisere, Kamunkhwala Gausi, Joseph Musaazi, Allan Buzibye, Denis Omali, Rob Aarnoutse, Mohammed Lamorde, Kelly E Dooley, Derek James Sloan, Paolo Denti, Christine Sekaggya-Wiltshi |
Temporal offset association between the number of irinotecan-related adverse reactions and pharmacogenomic studies: A cross-correlation analysis. Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society 2023 1 31 (1): 180-183. Kong Lingti, Rong Li, Xie Mengyuan, Wang Muh |
Population Pharmacokinetics of Sacituzumab Govitecan in Patients with Metastatic Triple-Negative Breast Cancer and Other Solid Tumors. Clinical pharmacokinetics 2024 4 . Abhishek G Sathe, Indrajeet Singh, Pratap Singh, Paul M Diderichsen, Xiaohui Wang, Peter Chang, Atiya Taqui, See Phan, Sandhya Girish, Ahmed A Othm |
Impact of Genetic Variants in ABCG2, NR1I2 and UGT1A1 on the Pharmacokinetics of Dolutegravir in Children. Journal of acquired immune deficiency syndromes (1999) 2024 1 . Stephen A Spector, Sean S Brummel, Audrey Chang, Andrew Wiznia, Theodore D Ruel, Edward P Acosta, |
Clinical and genetic risk factors associated with neonatal severe hyperbilirubinemia: a case-control study based on the China Neonatal Genomes Project. Frontiers in genetics 2024 1 14 1292921. Xiao Wang, Tiantian Xiao, Jin Wang, Bingbing Wu, Huijun Wang, Yulan Lu, Yaqiong Wang, Bin Chen, Liyuan Hu, Yun Cao, Rong Zhang, Guoqiang Cheng, Laishuan Wang, Zhihua Li, Xinran Dong, Lin Yang, Wenhao Zh |
Associations between UGT1A1, SLCO1B1, SLCO1B3, BLVRA and HMOX1 polymorphisms and susceptibility to neonatal severe hyperbilirubinemia in Chinese Han population. BMC pediatrics 2024 1 24 (1): 82. Juan Fan, Hua-Yun He, Huan-Huan Li, Pi-Liu Wu, Lei Tang, Bo-Yin Deng, Wen-Hui Dong, Jian-Hui Wa |
TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes. Annals of oncology : official journal of the European Society for Medical Oncology 2024 1 . Y Loriot, D P Petrylak, A Rezazadeh Kalebasty, A Fléchon, R K Jain, S Gupta, M Bupathi, P Beuzeboc, P Palmbos, A V Balar, C E Kyriakopoulos, D Pouessel, C N Sternberg, J Tonelli, M Sierecki, H Zhou, P Grivas, P Barthélémy, S T Taga |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: